Reactive oxygen species production by circulating monocytes: Insights from pathophysiology to clinical hypertension

Journal of Human Hypertension

Volumn 20, Issue 5, 2006, Pages 307-309

  Lim, H S ^a   Patel, J V ^a   Lip, G Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; FLOW CYTOMETRY; HUMAN; HYPERTENSION; MOLECULAR MECHANICS; MONOCYTE; NOTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; CAROTID STENOSIS; FLOW CYTOMETRY; HUMANS; HYPERTENSION; MONOCYTES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33646072181     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001994     Document Type: Note

References (20)

1. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003; 41: 1096-1101.
2. Lacy F, O'Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291-303.
3. Raij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: Role of superoxide anion. J Hypertens 2001; 19: 891-897.
4. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984; 4: 323-340.
5. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
6. Cooke CL, Davidge ST. Peroxynitrite increases iNOS through NF-kappa B and decreases prostacyclin synthase in endothelial cells. Am J Physiol 2002; 282: C395-C402.
7. Watanabe T, Yasunari K, Nakamura M, Maeda K. Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Human Hypertens 2006, this issue.
8. Geng YJ, Libby P. Progression of atheroma: A struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002; 22: 1370-1380.
9. Zeng X, Dai J, Remick DG, Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 2003; 93: 311-320.
10. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-438.
11. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
12. Lim HS, Lip GY, Blann AD. Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. J Clin Endocrinol Metab 2004; 89: 5377-5381.
13. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: Current evidence. J Hypertens 2002; 20: 2317-2325.
14. Tartiere JM, Kesri L, Safar H, Girerd X, Bots M, Safar ME et al. Association between pulse pressure, carotid intima-media thickness and carotid and/or iliofemoral plaque in hypertensive patients. J Hum Hypertens 2004; 18: 325-331.
15. Stamatelopoulos KS, Kalpakos D, Protogerou AD, Papamichael CM, Ikonomidis I, Tsitsirikos M et al. The combined effect of augmentation index and carotid intima-media thickness on cardiovascular risk in young and middle-aged men without cardiovascular disease. J Hum Hypertens 2006; 20(4): 273-279.
16. Takiuchi S, Kamide K, Miwa Y, Tomiyama M, Yoshii M, Matayoshi T et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004; 18: 17-23.
17. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al., British Hypertension Society. Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-185.
18. European Society of Hypertension-European Society of Cardiology Guidelinesn Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053. No abstract available. Erratum in: J Hypertens. 2003; 21(11): 2203-2204. J Hypertens. 2994; 22(2): 435.
19. Thuillez C, Richard V. Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens 2005; 19: S21-s25.
20. Ridker PM, JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trial. Circulation 2003; 108: 2292-2297.